Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | CUL4A | Q13619 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10660181 | 0.93 | SMN1; SMN2 (0.38) | SMN1; SMN2ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL2255922 | 0.91 | SMN1; SMN2 (0.36) | SMN1; SMN2ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL6286272 | 0.91 | SMN1; SMN2 (0.36) | SMN1; SMN2ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL9296553 | 0.91 | CYP3A4 (0.43) | SMN1; SMN2ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL9483114 | 0.91 | CYP3A4 (0.43) | SMN1; SMN2ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL6004102 | 0.88 | CYP3A4 (0.41) | SMN1; SMN2ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL15053474 | 0.88 | CYP3A4 (0.41) | SMN1; SMN2ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL9297116 | 0.88 | CYP3A4 (0.41) | SMN1; SMN2ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL3871150 | 0.86 | SMN1; SMN2 (0.43) | SMN1; SMN2ALOX15CYP3A4CASP1CASP7 | |
| SCHEMBL28256785 | 0.83 | ELANE (0.36) | ALDH1A1L3MBTL1POLBTDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110961151-B | Ruthenium-copper bimetallic catalyst, preparation method and application thereof | 扬州大学 | 2022-08-12 | — | — | CN | claimed |
| CN-110961151-A | Ruthenium-copper bimetallic catalyst, preparation method and application thereof | 扬州大学 | 2020-04-07 | — | — | CN | claimed |
| CN-110961151-B | Ruthenium-copper bimetallic catalyst, preparation method and application thereof | 扬州大学 | 2022-08-12 | — | — | CN | disclosed |
| CN-110961151-A | Ruthenium-copper bimetallic catalyst, preparation method and application thereof | 扬州大学 | 2020-04-07 | — | — | CN | disclosed |
| US-6919291-B2 | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-07-19 | — | — | US | disclosed |
| US-20040110631-A1 | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-06-10 | — | — | US | disclosed |
| EP-1349653-A2 | FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2003-10-08 | — | — | EP | disclosed |
| WO-2002036639-A2 | FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2002-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110631-A1 | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | FZD7, FOS, COG4 | SMN1; SMN2 4185/4885ALOX15 386/4885CYP3A4 1344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.